This site is intended for healthcare professionals
Respiratory Care

ERS 2020

Read time: 30 mins

ERS 2020

Explore this section for the latest updates in asthma diagnosis, treatment and management from ERS International Congress 2020 Virtual.

The hot topic articles have been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content.

Rethinking asthma

Discover the latest updates in asthma diagnosis, treatment and management from ERS International Congress 2020 Virtual. From the contribution asthma phenotypes and endotypes could make in daily clinical practice to the latest research on the role of pharmacotherapy in the management of disease.

Register free for full access to medthority.com

Digital health in airway disease

Find out the latest updates on digital health in airway disease including the potential role of digital technology to enhance the diagnosis, treatment and management of asthma from ERS International Congress 2020 Virtual.

Register free for full access to medthority.com

The environmental impact of asthma and COPD therapy

Many inhalers for conditions such as asthma contain propellants that are known to be potent greenhouse gases, but is the global warming potential of these inhalers having a significant impact?

Register free for full access to medthority.com

Latest insights in respiratory management

Find out the latest insights in asthma and COPD management from ERS International Congress 2020 Virtual, sharing updates in prevention, risk mitigation, diagnostics, treatment and management strategies.

Register free for full access to medthority.com

Early life origins of respiratory illness

Explore research into the complex mechanisms and pathways involved in the relationship between early-life events and chronic respiratory diseases that is opening up new opportunities for the treatment and management of respiratory illness.

Register free for full access to medthority.com

Welcome:

The ERS 2020 content has been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content.
Topic 1: GLRESP/QVM149/0138, Topic 2: GLRESP/QVM149/0170, Topic 3: GLRESP/QVM149/0171, Topic 4: GLRESP/QVM149/0172, Topic 5: GLRESP/QVM149/0173.